Financials
- Market Capitalization 32.38 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
2.8
ratio cours/chiffre d'affaires
0.88
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4392 | KYNB Kyntra Bio, Inc. - Common Stock | 8.55 USD | +0.71% | +7.95% | +23.38% | -10.09% | 34.62 M USD | ||
| 4408 | CNTX Context Therapeutics Inc. - Common Stock | 0.36 USD | 0.00% | -7.69% | -28.00% | -56.10% | 33.08 M USD | ||
| 4424 | QNCX Quince Therapeutics, Inc. - Common Stock | 31.32 USD | +2.52% | -7.99% | +7.37% | +1869.81% | 31.85 M USD | ||
| 4432 | BCTX BriaCell Therapeutics Corp. - Common Shares | 3.57 USD | +1.13% | -4.03% | +1.71% | -54.52% | 31.06 M USD |